Independent healthcare robotics advisory · Asia

Know if the robot will pay off. Before you sign.

Physician-led appraisal of surgical, rehabilitation, laboratory and hospital-logistics robots for hospitals across Asia, and for the companies that sell to them. Clinical evidence and the full cost, side by side, in language a board can act on.

  • Physician-led (MBBS)
  • No vendor commissions
  • Fixed scope, fixed fee
Illustration of a robotic-assisted operating theatre with a multi-arm robot, surgical light and surgeon console
Regulators and standards we map to MFDS KoreaCDSCO IndiaNMRA Sri LankaHSA SingaporeFDAEU MDRIEC 80601-2-77IEC 80601-2-78ISO 14971IEC 62304

Why now

More robots, lower prices, and no universal answer.

Vendor choice is widening fast, especially in Asia. The published evidence says the economics depend on your own case volume, so no brochure can answer the question for your hospital.

1,721
da Vinci systems placed worldwide in 2025, with procedures up about 18% on 2024.
Intuitive, full-year 2025 results, January 2026
40–50%
lower system and maintenance cost reported for newer Asian platforms such as Revo-i, hinotori, Toumai and SSI Mantra.
Lee and Rha, AUANews, March 2025
40–300
cases a year: the published range of break-even volumes for cost-effective robotic surgery. No single threshold applies.
Garavini et al., Journal of Robotic Surgery, 2026

Built for Asian hospitals

Most robotics advice is written for American and European hospitals. Asian hospitals face different prices, payers, staffing and regulators, and since December 2025 a wider field of competitors to da Vinci, including Medtronic's Hugo in the US. Robotingale starts from your market.

South KoreaIndiaSri LankaSingaporeMalaysiaIndonesiaThailandVietnamRemote work worldwide

Offers

Two kinds of client, one standard of evidence.

Hospitals buy robots and companies sell them. Both need the same honest answer: does this robot improve care at a cost the hospital can carry?

For hospitals and health systems

Decide, buy and use robots well

Start here

Robot Purchase Second Opinion

from US$2,500Fixed fee · 10 working days

An independent review of the vendor proposal on your desk, before you commit capital.

  • Clinical fit for your case mix
  • Evidence grade for your procedures
  • Seven-year total cost of ownership
  • Break-even case volume
  • Contract clauses to change
Request a Second Opinion

Best for: a vendor quote is on your desk and a decision is due within six months. Already own a robot? See the Utilisation Review.

Board-Ready Business Case

ScopedTypically 4 to 6 weeks

Graded evidence, a full economic model with sensitivity ranges, and a paper your board and finance team can test.

Discuss scope

Vendor Selection and Negotiation Support

ScopedTypically 6 to 8 weeks

Weighted criteria, side-by-side vendor scoring, and the terms that decide total cost: instruments per case, service, uptime and volume commitments.

Discuss scope

Utilisation Review

ScopedTypically 3 to 4 weeks

For hospitals that already own a robot. Find out why theatre time sits idle and what would lift case volume to where the robot pays.

Discuss scope

For robotics companies

Win hospital buyers in Asia

Start here

Hospital Value Story Audit

from US$3,000Fixed fee · 2 weeks

We test your clinical and economic claims the way a sceptical hospital committee would, and show you what will not survive the meeting.

  • Claim-by-claim evidence check
  • Gaps a buyer or payer will raise
  • Prioritised fix plan
Request an audit

Best for: a tender, distributor pitch or launch in Asia within the next two quarters.

Health-Economic Model and Value Dossier

ScopedTypically 6 to 10 weeks

A transparent model hospitals can run with their own numbers, and a dossier that answers procurement before it asks.

Discuss scope

Asia Evidence and Market-Entry Plan

ScopedTypically 4 to 6 weeks

The evidence that buyers and health-technology assessment bodies expect in Korea, India, Sri Lanka and South-East Asia, sequenced against your launch.

Discuss scope

Free

Thirty-minute discovery call

Describe the decision in front of you. You leave with the questions that matter and a clear view of whether a paid engagement makes sense. No obligation.

Book the free call

Prices in US dollars. Fixed-fee offers start from the price shown and have a written scope agreed before work begins. Scoped work is quoted after the free call. Public institutions in low- and middle-income countries can ask about adjusted terms.

Domains

Where robots meet the hospital.

Each domain has its own evidence base, its own cost drivers and its own way of failing. The appraisal follows the domain.

Close-up illustration of a surgical robot arm above an operating table

Surgical robotics

Will the console earn its place in your theatre?

Robot-assisted systems change operating time, length of stay, conversion rates and consumable spend. Which of those matter depends on your procedures, your surgeons and your annual case volume.

Questions we answer

  • How many cases a year does this system need to break even?
  • Which procedures show a patient benefit over laparoscopic or open surgery?
  • What does the team learning curve cost in theatre time?
IEC 80601-2-77IEC 60601-1ISO 14971FDAEU MDR
Illustration of a patient walking in a powered exoskeleton between parallel bars with a therapist and gait graph

Rehabilitation and assistive robots

Do more repetitions mean better recovery for your patients?

Exoskeletons, gait trainers, upper-limb robots and tele-rehabilitation can raise therapy dose and release therapist time. The gain depends on patient selection, session design and what your payer will fund.

Questions we answer

  • Which patient groups show a meaningful functional gain?
  • How much therapist time is released, and where does it go?
  • Is the device reimbursable, or does the hospital carry the cost?
IEC 80601-2-78ISO 13482ISO 14971IEC 62304
Illustration of a laboratory pipetting robot above a 96-well plate with a sample rack and analyser

Laboratory automation

Where does automation shorten turnaround, and where does it only move the bottleneck?

Liquid handling, pathology workflows and cell-processing platforms promise fewer errors and fewer staff hours. Test menu, sample volume, information-system integration and validation effort decide the return.

Questions we answer

  • What volume and test mix justify a workcell?
  • How long does validation take, and who does it?
  • What happens to turnaround and error rate during downtime?
ISO 15189IEC 61010-2-101EU IVDRIEC 62304
Illustration of an autonomous delivery robot travelling down a hospital corridor

Hospital logistics and automation

Which ward tasks can a robot take over without creating new ones?

Delivery robots, pharmacy automation, UV disinfection and patient-handling aids release staff hours only when they fit lifts, networks, infection-control rules and the way ward teams already work.

Questions we answer

  • How many staff hours are released, and who reclaims them?
  • Does it work with your lifts, Wi-Fi and building layout?
  • What is the fallback when it stops?
ISO 3691-4IEC 81001-5-1IEC 62304ISO 14971

The Robotingale method

Six lenses, one appraisal rose.

Florence Nightingale used polar-area diagrams to make evidence impossible to ignore. Every engagement ends with the same picture for your robot: what the brochure claims against what the appraisal supports.

  1. Frame the clinical need

    Define the patient problem, the current pathway and the outcome that has to move.

  2. Appraise the evidence

    Grade trials, registries and real-world data. Separate technical performance from patient benefit.

  3. Model the economics

    Budget impact, total cost of ownership, payback, break-even volume and, where relevant, cost per quality-adjusted life year. Every model carries sensitivity ranges.

  4. Design the pilot and governance

    Set the protocol, success thresholds, training plan and stop rules before the contract is signed.

  5. Track outcomes

    Compare results with the model at set intervals and adjust the plan.

Budget impactTotal cost of ownershipPayback periodBreak-even volumeICER / QALYSensitivity analysis
Appraisal roseSelect a wedge
Vendor claimIndependent appraisal

Illustrative example device. Scores are invented to show the format. Wedge area is proportional to score, as in Nightingale's diagrams.

What a Second Opinion contains

A short report your board will read.

  1. Decision summaryGo, no-go or renegotiate, on one page
  2. Clinical fitYour procedures, case mix and surgeon pipeline
  3. Evidence gradeWhat trials and registries show for your intended use
  4. Seven-year costCapital, instruments, service, training and downtime
  5. Break-even volumeCases a year needed, with low and high ranges
  6. Contract reviewClauses to change and questions to send back

Delivered with the working cost model as a spreadsheet, so your finance team can change any assumption.

Free checklist

12 questions to ask a robot vendor before you sign

  1. What is the all-in cost per case, including instruments and drapes, at our expected volume?
  2. What does service cost from year two, and what uptime is guaranteed in writing?
  3. Are instrument prices fixed for the full contract term?
  4. Is there a minimum annual volume commitment, and what happens if we miss it?
  5. How long will this model be supported, and what will an upgrade cost?
  6. How quickly can a local engineer be on site when the system is down?
  7. Which training, proctoring and credentialing costs fall on us?
  8. Which published outcomes exist for the procedures we plan to do?
  9. Which hospitals of our size and case mix can we call as references?
  10. Who owns the procedure data and video the system records?
  11. What cybersecurity evidence can you share, such as a software bill of materials?
  12. What are the exit terms if the programme does not reach volume?

Independence

We work for the client paying us. Never for the vendor in the room.

Advising both hospitals and robotics companies is only credible with firm rules. These four are written into every engagement letter.

  • No commissionsNo referral fees, resale margins or success fees from any manufacturer.
  • A firewall between sidesWe do not appraise a product for a hospital while advising its maker, and we disclose past vendor work before you engage us.
  • Open modelsYou receive the working model. Every assumption is visible and your finance team can change it.
  • Confidential by defaultAn NDA before the first document if you want one. We never need patient-identifiable data.

Questions

What clients ask first.

How quickly can a Second Opinion start?

Most start within a week of the free call and are delivered in 10 working days, provided we receive the vendor proposal and your case-volume data at the start.

Are you independent of robot manufacturers?

Yes. Robotingale takes no commissions, referral fees or resale margins from manufacturers, does not appraise a product for a hospital while advising its maker, and discloses past vendor work in writing before an engagement starts.

Why focus on Asia?

Asian hospitals face a wider choice of surgical platforms, different prices and payers, and their own regulators, from MFDS in Korea to CDSCO in India and NMRA in Sri Lanka. Advice built for American and European hospitals often misses those differences. Remote engagements elsewhere are welcome.

What do we receive at the end?

A written report or dossier for each engagement, plus the working economic model as a spreadsheet, so your finance team can test every assumption.

Can a small or public hospital afford this?

The Second Opinion is priced for exactly that buyer. Against a multi-year capital and service commitment, an independent check is a small cost. Public institutions in low- and middle-income countries can ask about adjusted terms.

We are a robotics company. Can you help?

Yes. Typical work covers value-story audits, health-economic models for hospital buyers and payers, and Asia evidence planning. Robotingale will not write claims that the evidence does not support.

Do you give medical, legal or regulatory advice?

No. Robotingale provides advisory analysis on technology decisions. It does not give patient-specific medical advice or legal advice, or prepare regulatory submissions. Regulatory findings summarise public status and standards and should be confirmed with your own regulatory counsel.

Free 30-minute call

Tell us which robot you are weighing.

A short description is enough. You will get a reply with a proposed call time.

  1. 1You describe the decision, the setting and the deadline.
  2. 2We reply with a call time and the questions we will ask.
  3. 3After the call you decide whether a paid offer fits. No obligation.